The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(1H-imidazol-1-yl)phenyl)-6-(4-iodophenyl)-pyrimidin-2-amine ID: ALA2296872
PubChem CID: 76327622
Max Phase: Preclinical
Molecular Formula: C19H14IN5
Molecular Weight: 439.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(-c2ccc(I)cc2)cc(-c2ccc(-n3ccnc3)cc2)n1
Standard InChI: InChI=1S/C19H14IN5/c20-15-5-1-13(2-6-15)17-11-18(24-19(21)23-17)14-3-7-16(8-4-14)25-10-9-22-12-25/h1-12H,(H2,21,23,24)
Standard InChI Key: GNVXNDXHKGCINN-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
13.7423 -16.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7411 -17.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4492 -17.5104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1588 -17.1009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1560 -16.2783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4474 -15.8730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0385 -15.8692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9528 -15.0566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1534 -14.8868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7450 -15.5947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2920 -16.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8672 -17.5084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8636 -18.3260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5711 -18.7334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2792 -18.3236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2752 -17.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5672 -17.0985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5720 -19.5506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9760 -17.0919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6860 -17.4986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3912 -17.0871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3875 -16.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6727 -15.8642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9705 -16.2781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0925 -15.8559 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
1 7 1 0
4 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
14 18 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
16 19 1 0
22 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 439.26Molecular Weight (Monoisotopic): 439.0294AlogP: 4.18#Rotatable Bonds: 3Polar Surface Area: 69.62Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.06CX LogP: 4.66CX LogD: 4.64Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.49Np Likeness Score: -1.66
References 1. Bukhari MH, Ahmad M, Hussain T, Umar S, Ahmad N. (2013) Synthesis and biological studies of a novel series of 4-(4-(1H-imidazol-1-yl)phenyl)-6-arylpyrimidin-2-amines, 22 (11): [10.1007/s00044-013-0523-6 ]